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patients. This study challenges the pharmacokinetic rationale for a
loading dose similar to a study byGregoire N, et al (2014).
http://dx.doi.org/10.1016/j.ijid.2016.02.312
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Background: Acinetobacter baumanii are one of main bacte-
rial pathogen caused nosocomial infection according International
Guidelines of Infection Control (2015). Last 4 years the part of noso-
comial infection caused byAcinetobacter baumanii are dramaticaly
grows.
Methods & Materials: In the multicenter study 200 strains
of Acinetobacter baumanii were collected in period 2012-
2015yy. Strains were collected in 3 tertiary hospitals in the
Central Kazakhstan. All strains were identiﬁed by MALDI-TOF
mass-spectrometry and typed by PCR detection of OXA-51 car-
bapenemase as A.baumanii speciﬁc label. The sensitivity testing
were by micro dilution methods with CLSI criteria using. The OXA-
23 and OXA-40 carabapenemases genes detection made by PCR
with commercial kits (Interlab Service, Russia). The statistical anal-
ysis (MIC90, average MIC, 95% Conﬁdential Interval) was made by
WhoNet 6.2 database.
Results:All isolated strainsare resistance tomainpartof antimi-
crobial drug (pic. 1). During fourth years period the resistance to
carbapenems were increased: to imipenem 64,5%; 95%CI 45,5-80,2
(2012 year) to 81,2; 95%CI 66,8-90,5 (2015 year). The resis-
tance growth by logarithmyc depence (y =12,257ln(x) + 65,537;
R2 =0,9612). The testing of general linear hypothesis in regression
situation for logarithmic model can predict level of resistance in
2016 at over 85% (pic.2). The dynamic of increasing to meropenem
was the same and changed from 61.3% (2012) to 84,5% (2015y).
In all cases of resistance to carbapenems the gene blaOXA-23
carbapenemase was detected. The quantitavive characteristics of
Pic 1. The resistance to antibiotics of nosocomial srtains A.baumanii isolated in the
Central Kazakhstan’s tertiary hospitals (2015).
Pic 2. The dynamic of the resistance to imipenem of nosocomial strains A.baumanii
isolated in Central Kazakhstan’s tertiary hospitals (2012-2015yy).
Table 1
The sensitivity to antimicrobials of nosocomial strains A.baumanii isolated in fourth
tertiary hospitals in the Central Kazakhstan (2012-2015yy.)
sensitivity to antimicrobials are present in table 1. The high part
of studied strains were sensetivity to aminoglycosides: netilmycin
(97,9%), sisomycin (91,3%), tobramycin (100%) and colistine (89,6%)
and tigecycline (100%). However all preparationsmentioned above
are not registered in Kazakhstan so can’t using for treatment infec-
tions caused A.baumanii.
Conclusion: The resistance to carbapenems in the fourth ter-
tiary hospitals in the Central Kazakhstan are increased during
2012-2015yy. The major cases of resistance to beta-lactams were
linked with OXA-23 carbapenemase production. Some part of
antibiotics (netilmycin, sisomycin, tobramycin, colistin and tige-
cycline) has high activity against studied nosocomial strain of
A.baumanii but this drug not registered in Kazakhstan.
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Background: Recent clinical reports have highlighted the
increasing occurrence of methicillin-resistant Staphylococcus
aureus (MRSA), vancomycin-resistant enterococci (VRE) and other
antibiotic-resistant human pathogenic microorganisms. Transition
metal complexes of heterocyclic moieties or/with Schiff’s base
components have been reported to show promising nucleolytic
activity. In an effort to develop newer generation low molecular
